Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Prevalence and Factors of Sarcopenia in Patients With Primary Sjogren's Syndrome
Authors not listed
Acibadem University · 2021
Abstract
Sarcopenia is a progressive condition characterized by decline in muscle strength and muscle mass. Although the mechanism of sarcopenia has not been fully elucidated, it may be caused by protein-poor diet, vitamin D deficiency, hormonal changes, increase in inflammatory cytokine level and oxidative stress. For this reason, it is thought that determining the prevalence of sarcopenia in rheumatological diseases with chronic inflammation and protecting patients from possible comorbidities with appropriate interventions may be an important factor in maintaining and improving the functional levels and quality of life of patients.
The aim of our study was to investigate the prevalence and its associated factors of sarcopenia in individuals with primary Sjögren's Syndrome.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-05 MST
Cite this
APA
Anonymous. (2021). Prevalence and Factors of Sarcopenia in Patients With Primary Sjogren's Syndrome. <em>Acibadem University</em>. https://clinicaltrials.gov/study/NCT05015114
Vancouver
Anonymous. Prevalence and Factors of Sarcopenia in Patients With Primary Sjogren's Syndrome. Acibadem University. 2021.
BibTeX
@misc{anon2021Preval,
title = {Prevalence and Factors of Sarcopenia in Patients With Primary Sjogren's Syndrome},
author = {Anonymous},
journal = {Acibadem University},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Antalya Training and Research Hospital 2025
Open access · US-GOV
Investigation of Possible Sarcopenia and/or the Presence of Sarcopenia in Patients With Primary Sjögren's Syndrome and Its Effect on Functional Status
Acibadem University 2021
Open access · US-GOV
Prevelance of Frailty and Its Associated Factors in Patients With Axial Spondyloarthritis
Selcuk University 2025
Open access · US-GOV
Sarcopenia and Related Factors in Patients With Multiple Sclerosis
Dokuz Eylul University 2023
Open access · US-GOV
Evaluation of Sarcopenia and Associated Factors in Patients With Lipedema
Ankara City Hospital Bilkent 2025
Open access · US-GOV
Evaluation of the Association Between Serum Selenium Levels and Sarcopenia and Frailty in Patients Receiving Maintenance Hemodialysis
Tarsus University 2025
Open access · US-GOV